Inhibikase Therapeutics, Inc. (IKT)

Last Closing Price: 1.96 (2025-06-06)

Loss Ratio (Annual)

Loss Ratio: A measure of profitability used by an insurance company to indicate how well it is performing in its daily operations. The loss ratio is calculated by taking the incurred underwriting losses and then dividing them by earned premium. Calculated as: Underwriting Losses Total / Net Premiums Earned

Inhibikase Therapeutics, Inc. (IKT) Loss Ratio data is not available.

Figures for fiscal year ending 2024-12-31
Income Statement Financials
--
$-27.52M
--
--
$28.59M
$-28.59M
$1.07M
$-27.52M
$-27.52M
$-27.52M
$-27.52M
$-27.52M
$-27.52M
$-28.59M
$-28.56M
23.71M
23.71M
$-1.16
$-1.16
Balance Sheet Financials
$98.45M
$0.05M
$0.15M
$98.60M
$3.73M
--
--
$3.73M
$94.87M
$94.87M
$94.87M
69.36M
Cash Flow Statement Financials
$-19.15M
$-37.00M
$103.48M
$9.17M
$56.49M
$47.33M
$8.14M
--
--
Fundamental Metrics & Ratios
26.37
--
--
--
--
--
--
--
--
--
--
$-19.15M
Loss Ratio
--
--
--
--
--
--
--
-29.01%
-29.01%
-27.91%
-29.01%
$1.37
$-0.81
$-0.81